- Year selection
- 2022
- 2033
-
2026-10-28
CLOSURE OF REGISTER OF MEMBERS FOR EXTRAORDINARY GENERAL MEETING
-
2026-10-16
VOLUNTARY ANNOUNCEMENT THE FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF Y225 FOR TREATMENT OF HEMOPHILIA A
-
2026-10-16
VOLUNTARY ANNOUNCEMENT THE FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF Y225 FOR TREATMENT OF HEMOPHILIA A
-
2026-10-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
-
2026-09-30
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO(1) CONNECTED TRANSACTION IN RESPECT OF THE PROPOSED ISSUE OFNEW DOMESTIC SHARES UNDER SPECIFIC MANDATE;(2) APPLICATION FOR WHITEWASH WAIVER; AND(3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
-
2026-09-30
UPDATE ON THE QUALIFICATION OF JOINT COMPANY SECRETARY AND RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF PROCESS AGENT
-
2026-09-16
2026 INTERIM REPORT
-
2026-09-10
EXCHANGE NOTICE - RESUMPTION OF TRADING
-
2026-09-09
ANNOUNCEMENT(1) CONNECTED TRANSACTION IN RESPECT OF THE PROPOSED ISSUEOF NEW DOMESTIC SHARES UNDER SPECIFIC MANDATE;(2) APPLICATION FOR WHITEWASH WAIVER;(3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION;(4) APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER; AND(5) RESUMPTION OF TRADING
-
2026-09-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026
E-Mail：info@yzybio.com
Address：Biolake, C2-1, No. 666 High-tech Avenue, Wuhan, Hubei, China
